Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdayMar 12, 2019 3:30 pm

Electra Meccanica Vehicles Corp. (SOLO) Presenting at 2nd Annual LD Micro Virtual Conference

Electra Meccanica Vehicles (NASDAQ: SOLO) is a designer and manufacturer of electric vehicles. The company builds the innovative, all-electric SOLO, a single passenger vehicle developed to revolutionize the way people commute, and is developing the Tofino, an elegant high-performance two-seater electric roadster sports car. Both vehicles are designed for the ultimate driving experience while making commuting more efficient, cost-effective and environmentally friendly. Intermeccanica, a subsidiary of Electra Meccanica, has successfully been building high-end specialty cars for 59 years. The Electra Meccanica family aims to deliver next generation affordable electric vehicles to the masses. For more information, visit the company's website…

Continue Reading

TuesdayMar 12, 2019 3:00 pm

Data I/O Corp. (DAIO) Presenting at 2nd Annual LD Micro Virtual Conference

Data I/O (NASDAQ: DAIO) is developing innovative solutions to enable the design and manufacture of electronic products for automotive, industrial/Internet-of-Things, consumer electronics, markets and the company’s programming center and contract manufacturing partners. Data I/O customers manufacture hundreds of millions of products each year using Data I/O programming solutions to reliably, securely, and cost-effectively deliver Intellectual Property into programmable devices. The company’s expertise in programmable integrated circuits, global supply chain processes, factory integration and IP management and protection helps bring innovative new products to life. For more information, visit the company's website at www.dataio.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information…

Continue Reading

TuesdayMar 12, 2019 2:30 pm

Citius Pharmaceuticals Inc. (CTXR) Presenting at 2nd Annual LD Micro Virtual Conference

Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives, cancer care and unique prescription products that use innovative, patented or proprietary formulations of previously approved active pharmaceutical ingredients. Citius seeks to achieve leading market positions by providing therapeutic products that address unmet medical needs. By using previously approved drugs with substantial safety and efficacy data, the company seeks to reduce risks associated with pharmaceutical product development and regulatory requirements. Citius develops products that have intellectual property protection and competitive advantages to existing therapeutic approaches. For…

Continue Reading

TuesdayMar 12, 2019 2:00 pm

Cemtrex Inc. (CETX) Presenting at 2nd Annual LD Micro Virtual Conference

Cemtrex (NASDAQ: CETX) is a diversified technology company driving innovation in a wide range of sectors, including smart technology, virtual and augmented realities, advanced electronic systems, industrial solutions, and intelligent security systems. Cemtrex is the manufacturer of the SmartDesk, the world’s most advanced workstation. For more information, visit the company's website at www.cemtrex.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication…

Continue Reading

TuesdayMar 12, 2019 1:30 pm

Cardiol Therapeutics Inc. (TSX: CRDL) (CRTPF) Presenting at 2nd Annual LD Micro Virtual Conference

Cardiol Therapeutics (TSX: CRDL) (OTC: CRTPF) is engaged in the research and commercial development of pharmaceutical cannabidiol products and targeted therapies for heart failure and cancer. The company is leveraging its expertise in pharmaceutical cannabinoids to develop proprietary formulations for three important medical markets: (1) commercializing a line of >99.5% purity pharmaceutically- manufactured cannabidiol products (with less than 10 ppm THC) in the market for medical cannabinoids; (2) developing nanotechnologies designed to deliver cannabinoids and other anti-inflammatory drugs for the treatment of heart failure; (3) and pursuing an immunotherapeutics program commencing with an innovative cancer immunotherapeutic in combination with cannabinoids…

Continue Reading

TuesdayMar 12, 2019 1:00 pm

BioSig Technologies Inc. (BSGM) Presenting at 2nd Annual LD Micro Virtual Conference

BioSig Technologies (NASDAQ: BSGM) is a medical technology company developing a proprietary biomedical signal processing platform designed to improve the electrophysiology (EP) marketplace. BioSig Technologies is preparing to commercialize its PURE EP System, a novel cardiac signal acquisition and display system engineered to assist electrophysiologists in clinical decision-making during procedures to diagnose and treat patients with abnormal heart rates and rhythms. BioSig’s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. For more information, visit the company's website at www.biosigtech.com. About NetworkNewsWire NetworkNewsWire (NNW) is…

Continue Reading

TuesdayMar 12, 2019 12:55 pm

City View Green Holdings Inc. (CSE: CVGR) Enters Canadian Securities Exchange with Focus on Building Quality in Cannabis Markets

City View Green Holdings has completed a move to the Canadian Securities Exchange to boost its worldwide potential for cannabis production CVGR will focus on growing high-quality flower in the pursuit of creating top-notch extracts for edibles, distillates and water-soluble products The company has acquired the professional experience of a master grower who formerly founded a TSX Venture Exchange-listed cannabis issuer City View Green Holdings Inc. (CSE: CVGR), a company focused on establishing a diverse portfolio as it assesses entities in the cannabis space for potential acquisition, is crafting a formidable strategy for world markets in which medicinal and adult…

Continue Reading

TuesdayMar 12, 2019 12:30 pm

Biomerica Inc. (BMRA) Presenting at 2nd Annual LD Micro Virtual Conference

Biomerica (NASDAQ: BMRA) is a global biomedical company that develops, manufactures and markets advanced diagnostic products used at the point-of-care and in hospital/clinical laboratories for the early detection of medical conditions and diseases. Biomerica primarily focuses on products for Gastrointestinal Disease, Diabetes and esoteric testing. The Biomerica InFoods IBS patent-pending product identifies specific foods that when removed may alleviate an individual's IBS symptoms. The point-of-care product is being developed to allow physicians to perform tests in-office using a finger stick blood sample. For more information, visit the company's website at www.biomerica.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that…

Continue Reading

TuesdayMar 12, 2019 12:29 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Innovating on Numerous Fronts with DehydraTECH Drug Delivery Platform

Lexaria Bioscience is focusing on its unique technology for the delivery of bioactive compounds The company’s concentration on oral ingestion results in an option that often healthier than other delivery methods Its DehydraTECH technology has potential applications for nicotine absorption Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) focuses on technology for the improved delivery of bioactive compounds. Its DehydraTECH drug delivery platform fosters healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules. The company’s process changes the way edible cannabinoids enter the body (http://nnw.fm/8uGHp). A drug delivery innovator, Lexaria Bioscience is headquartered in…

Continue Reading

TuesdayMar 12, 2019 12:03 pm

Montel Williams, Ricki Lake and Henry Rollins to Speak at O’Cannabiz Conference & Expo in Toronto

Event slated to include a business conference, industry awards, an industry expo and a public expo Topics include growing and cultivation, cannabis science, health and wellness, and policy and regulations O’Cannabiz Conference & Expo expected to feature more than 120 world-class speakers, 7,000 attendees and 250 exhibitors O’Cannabiz Conference & Expo will bring together cannabis professionals and industry experts from throughout Canada and around the world on April 25–27 at the International Centre in Toronto. Celebrity speakers will include Montel Williams, Ricki Lake and Henry Rollins. Learn more at www.OCannabiz.com. Reserve tickets now and register at http://nnw.fm/Y5xQj. O’Cannabiz will offer…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000